SA

Shrikant Ashokrao Fulkar

Active Director Director DIN 06920181
DIN 06920181 First appointment Jan 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2015
Shareholding value •••• Premium profile

About Shrikant Ashokrao Fulkar

Data last updated:

Shrikant Ashokrao Fulkar is a Director at Medisign Remedies Private Limited (since 2015). The company operates in Chemicals. Medisign Remedies Private Limited reported revenue of ₹19.9 Lakh (FY 2024).

DIN 06920181
Primary Designation Director
Industry Chemicals
First Appointment 15 Jan 2015
Oldest Company Age 11 yrs
Largest company Medisign Remedies Private Limited · ₹19.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medisign Remedies Private Limited U74999MH2015PTC260964
Director15 Jan 20152015₹19.9 Lakh (FY 2024)Active

Board colleagues of Shrikant Ashokrao Fulkar

Directorship timeline

Open interactive timeline →
Medisign Remedies Private Limited
Premium access

Shareholding and investment profile for Shrikant Ashokrao Fulkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shrikant Ashokrao Fulkar

Shrikant Ashokrao Fulkar currently holds 1 directorship: Medisign Remedies Private Limited (Director, since 15 Jan 2015, revenue ₹19.9 Lakh (FY 2024)).

Shrikant Ashokrao Fulkar was first appointed on 15 Jan 2015 as Director at Medisign Remedies Private Limited.

The current boards of Shrikant Ashokrao Fulkar's companies include Amol Vijayrao Hore (Medisign Remedies Private Limited), Sachin Arun Hasti (Medisign Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available